Reassessing Dynavax Technologies Amidst the Sanofi Cash Acquisition Deal

Dynavax Technologies' share price closed at $15.50, with returns of 0.1% over 7 days, 0.6% over 30 days, 0.8% year to date, 22.0% over 1 year, 36.7% over 3 years, and 58.5% over 5 years. The company's valuation score is 2 out of 6, indicating it may be overvalued by 34.0% based on a Discounted Cash Flow analysis, which uses a 2 Stage Free Cash Flow to Equity approach.